Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Myc inhibitor OMO-103

A peptide inhibitor of the proto-oncogene Myc, with potential antineoplastic activity. Upon administration, Myc inhibitor OMO-103 enters cells, reaches the nucleus and inhibits Myc. This may inhibit tumor cell growth and proliferation. Myc, a proto-oncogene dysregulated in a variety of cancers, plays a role in the regulation of transcription and cell proliferation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:OMO 103
OMO-103
OMO103
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search